Who owns Syros Pharmaceuticals?

Top Holders and Investors of Syros Pharmaceuticals Stock

Find out what company owns Syros Pharmaceuticals, who bought Syros Pharmaceuticals this quarter, and who sold shares of Syros Pharmaceuticals stock?

Fund or Company Name Number of Shares Valued At As Of
Fmr 6.13M $63.68M Sep 2019
Sumitomo Mitsui Trust Holdings 4.63M $48.10M Sep 2019
Nikko Asset Management Americas 4.63M $48.10M Sep 2019
Redmile 3.89M $40.37M Sep 2019
Arch Venture 3.86M $40.02M Sep 2019
ARK Investment Management 3.83M $39.80M Sep 2019
Flagship Ventures Management 2.94M $30.50M Sep 2019
BlackRock 2.74M $28.49M Sep 2019
Vanguard 1.80M $18.64M Sep 2019
Samsara BioCapital 1.73M $17.01M Sep 2019
Deerfield Management Company 1.27M $13.17M Sep 2019
Baker Bros. Advisors 974835 $10.12M Sep 2019
Dimensional Fund Advisors 474616 $4.93M Sep 2019
Geode Capital Management 451425 $4.69M Sep 2019
683 Capital Management 429775 $4.46M Sep 2019
Northern Trust 426851 $4.44M Sep 2019
Jpmorgan Chase & Co 420586 $4.37M Sep 2019
Renaissance Technologies 286600 $2.97M Sep 2019
Charles Schwab Investment Management 199094 $2.07M Sep 2019
Bank of New York Mellon 111465 $1.16M Sep 2019
Nuveen Asset Management 107639 $1.12M Sep 2019
Alyeska Investment 100000 $1.04M Sep 2019
Inves 77214 $800709 Sep 2019
T. Rowe Price Associates 77156 $800879 Sep 2019
D. E. Shaw & Co 72938 $757096 Sep 2019
Susquehanna International 66177 $687579 Sep 2019
Deutsche Bank Aktiengesellschaft 58324 $555827 Sep 2019
California State Teachers Retirement System 53352 $553793 Sep 2019
State of Wisconsin Investment Board 52000 $539760 Sep 2019
Oxford Asset Management 47987 $498105 Sep 2019
Teachers Advisors 42419 $388133 Mar 2019
TIAA-CREF Investment Management 39754 $362954 Mar 2019
Rhumbline Advisers 38927 $404062 Sep 2019
Goldman Sachs 36447 $377955 Sep 2019
New York State Common Retirement Fund 35300 $366061 Sep 2019
Bridgeway Capital Management 33300 $345987 Sep 2019
Alliancebernstein 29100 $302058 Sep 2019
CalPERS 28700 $198030 Dec 2019
Wells Fargo & Company 27648 $286986 Sep 2019
Manufacturers Life Insurance Company 22623 $235957 Sep 2019
American International 21882 $226916 Sep 2019
Millennium Management 18775 $193945 Sep 2019
MetLife Investment Advisors 18369 $191037 Sep 2019
Barclays 17889 $185330 Sep 2019
PDT Partners 16033 $165941 Sep 2019
ProShare Advisors 15435 $160060 Sep 2019
Bank of America Corporation 13715 $142087 Sep 2019
Ing Investment Management 13602 $141052 Sep 2019
Metropolitan Life Insurance Company 13289 $137939 Sep 2019
Morgan Stanley 10076 $104588 Sep 2019
Winslow, Evans & Crocker 6300 $43974 Dec 2019
Legal & General 5791 $59994 Sep 2019
UBS Group AG 5007 $45213 Mar 2019
Victory Capital Management 4814 $50017 Sep 2019
Bnp Paribas Arbitrage, Snc 4490 $46606 Sep 2019
Citi 3722 $39006 Sep 2019
Bank Of Montreal /can/ 3043 $32012 Sep 2019
Tower Research Capital 2688 $28008 Sep 2019
Summit Investment Advisors 2602 $27008 Sep 2019
Mizuho Securities 800 $7000 Jun 2019
Ladenburg Thalmann Financial Services 650 $7000 Sep 2019
Simplex Trading 580 $5 Sep 2019
Daiwa Securities 270 $2999 Sep 2019
Meeder Asset Management 194 $2000 Sep 2019
Group One Trading 26 $0 Sep 2019

Who sold Syros Pharmaceuticals?

Fund Name Date Sold Shares Held Valued At
State Street Corporation March 31, 2019 420892 $3.85M
EcoR1 Capital June 30, 2019 248480 $2.30M
Candriam Luxembourg S.C.A. Sept. 30, 2019 169000 $1690
Two Sigma Advisers March 31, 2019 41000 $375150
Thomas Stevens, CFA" June 30, 2019 40370 $373826
Connor, Clark & Lunn Investment Management June 30, 2019 28838 $267039
GSA Capital Partners June 30, 2019 20070 $186048
Two Sigma Investments March 31, 2019 18539 $169075
Cutler June 30, 2019 1900 $17005